Back to results
US 2008/0306108 A1Published application
Substituted Pyridoxines As Anti-Platelet Agents
AssigneeMedicure International Inc.
InventorsWasimul Haque, James Diakur, Vinh Pham, Wenlian Zhang
Life of this patent
Estimating the term…
Abstract
Compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising a pyridoxine analogue.
Claims25
A compound of the formula:
- wherein
- R1 is OH, O-alkyl, or O-alkyl-aryl-R4, where R4 is H, —CN, amidine, alkyl, or cycloalkyl;
- R2 is alkyl;
- —(CH2)n′OH where n′ is an integer from 1 to 8;
- —(CH2)nCOOH where n is an integer from 0 to 8;
- —(CH2)nCOO(CH2)nCH3 where n is as defined above;
- (CH2)n-aryl-R5 where n is as defined above, and R5 is —CN or amidine;
- (CH2)n-aryl-aryl-R5, where n and R5 are as defined above;
- (CH2)n—NH-aryl-R5, where n and R5 are as defined above;
- (CH2)n—NH—CO-aryl-R4 where n and R4 are as defined above;
- (CH2)n—NH-aryl-aryl-R5 where n and R5 are as defined above;
- and (CH2)n—NH—CO-aryl-aryl-R6 where n is as defined above and R6 is —CN, —NO2, NH2, or amidine;
- R3 is —(CH2)n′OH where n′ is as defined above;
- (CH2)n—NH-aryl-R5, where n and R5 are as defined above;
- (CH2)n—NH—CO-aryl-R6 where n and R4 are as defined above;
- (CH2)n—NH-aryl-aryl-R5 where n and R5 are as defined above;
- and (CH2)n—NH—CO-aryl-aryl-R6 where n and R6 are as defined above;
- and
- R1 and R2 when taken together can form a compound of the formula
- wherein R3 is as defined above, with the proviso that R3 cannot be CH2—NH-Phenyl-R5 or CH2—NH-Phenyl-Phenyl-R5;
- and
- wherein only one of R4, R5, and R6 can be amidine;
- or a pharmaceutically acceptable salt thereof.
20 more elements
(canceled)
A compound of the formula
- wherein
- R1 is OH, OCH3, or OCH2-(4-tert-butylphenyl);
- R2 is CH2OH, CH2OCH3, CH2OBn, CH3,
- or COOR11 where R11 is H or alkyl;
- W is (CH2), where n′=1, 2 or 3, or C═O;
- X is (CH2)n where n=0, 1, 2, or 3, C═O, or CHCH2CO2H;
- Y is C—H, C—F, C—OCH3, C—OCF3, C—CF3, or N;
- R9 is
- Where R12 is H, OH or O-alkyl;
- R10 is H, CH2—Ar—R9 where R9 is defined as above;
- R1 and R2 taken together can form a compound of the formula IV
- wherein W, X, Y, R3 and R4 are as described above;
- and
- only one of R3 and R4 can be
- R12 is as described above;
- or a pharmaceutically acceptable salt thereof.
13 more elements
(canceled)
21-26. (canceled)
28-33. (canceled)
35-48. (canceled)
Dependencies are inferred from the claim text.